3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
32
Thoracic
11
Breast
6
Head & Neck
5
Gynecologic
5
Genitourinary
5
Dermatologic
5
NET
4
Endocrine
4
Sarcoma
2
Lymphoid
2
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Myeloid
1
Classical hematology
1
CNS
1
Conditions
Lymphoma, Non-Hodgkin
767
Lymphoma
713
Leukemia, Lymphocytic, Chronic, B-Cell
560
Lymphoma, Follicular
515
Lymphoma, Large B-Cell, Diffuse
440
Precursor Cell Lymphoblastic Leukemia-Lymphoma
331
Recurrence
317
Lymphoma, B-Cell
294
Neoplasms
261
Lymphoma, Mantle-Cell
251
Leukemia
231
Multiple Myeloma
189
Hodgkin Disease
179
Leukemia, Myeloid, Acute
178
Lymphoma, B-Cell, Marginal Zone
135
Lymphoma, T-Cell, Peripheral
119
Burkitt Lymphoma
105
Myelodysplastic Syndromes
101
Hematologic Neoplasms
100
Lymphoma, T-Cell, Cutaneous
88
Waldenstrom Macroglobulinemia
84
Leukemia, B-Cell
79
Lymphoma, T-Cell
74
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
65
Lymphoproliferative Disorders
57
Hematologic Diseases
57
Melanoma
54
Carcinoma, Non-Small-Cell Lung
54
Breast Neoplasms
51
Mycosis Fungoides
49
Interventions
alectinib
1
Tinzaparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Intestinal Neoplasms
×
Lymphoid
×
Clear all
NCT04644315
2023-08-07
ALpha-T
Hoffmann-La Roche
Phase 2
Terminated
1 enrolled
5 charts
NCT03099031
2019-12-16
PREDICARE
LEO Pharma
Completed
420 enrolled